Application of mass spectrometry to molecular diagnostics of viral infections

Expert Review of Molecular Diagnostics

Volumn 13, Issue 4, 2013, Pages 377-388

  Ganova Raeva, Lilia M ^a   Khudyakov, Yury E ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

DNA sequencing; infectious disease; mass spectrometry; molecular diagnostics; molecular surveillance; viral infection

Indexed keywords

ATMOSPHERIC PRESSURE; DNA SEQUENCE; ELECTROSPRAY MASS SPECTROMETRY; GEL ELECTROPHORESIS; GENOTYPE; HUMAN; IONIZATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEASUREMENT ACCURACY; METHYLATION; MICROBIAL IDENTIFICATION; MICROORGANISM DETECTION; MOLECULAR DIAGNOSTICS; MOLECULAR WEIGHT; NONHUMAN; PHYLOGENY; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; SEQUENCE ANALYSIS; VIRUS INFECTION; VIRUS TRANSMISSION;

COMMUNICABLE DISEASES; DNA METHYLATION; HUMANS; MASS SPECTROMETRY; NUCLEIC ACIDS; PATHOLOGY, MOLECULAR; SEQUENCE ANALYSIS, DNA; VIRAL PROTEINS; VIRUSES;

EID: 84877300242     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/erm.13.24     Document Type: Review

References (86)

1. Abbott R, Anbar M, Faden H, et al. Diagnosis of viral infections by multicomponent mass spectrometric analysis. Clin. Chem. 26(10), 1443-1449 (1980).
2. Anbar M, Dyer RL, Scolnick ME. Diagnosis of infectious hepatitis by multicomponent analysis with use of field ionization mass spectrometry. Clin. Chem. 22(9), 1503-1509 (1976).
3. Karas M, Hillenkamp F. Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Anal. Chem. 60(20), 2299-2301 (1988).
4. Fenn JB, Mann M, Meng CK, Wong SF, Whitehouse CM. Electrospray ionization for mass spectrometry of large biomolecules. Science 246(4926), 64-71 (1989).
5. Pusch W, Kostrzewa M. Application of MALDI-TOF mass spectrometry in screening and diagnostic research. Curr. Pharm. Des. 11(20), 2577-2591 (2005).
6. Drake RR, Boggs SR, Drake SK. Pathogen identification using mass spectrometry in the clinical microbiology laboratory. J. Mass Spectrom. 46(12), 1223-1232 (2011).
7. Meyer K, Ueland PM. Use of matrix-assisted laser desorption/ionization time-offlight mass spectrometry for multiplex genotyping. Adv. Clin. Chem. 53, 1-29 (2011).
8. Tost J, Gut IG. DNA analysis by mass spectrometry-past, present and future. J. Mass Spectrom. 41(8), 981-995 (2006).
9. Sakallah SA. Molecular diagnostics of infectious diseases: state of the technology. Biotechnol. Annu. Rev. 6, 141-161 (2000).
10. Schweickert B, Moter A, Lefmann M, Göbel UB. Let them fly or light them up: matrix-assisted laser desorption/ionization time of flight (MALDI-TOF) mass spectrometry and fluorescence in situ hybridization (FISH). APMIS 112(11-12), 856-885 (2004).
11. Ho YP, Reddy PM. Identification of pathogens by mass spectrometry. Clin. Chem. 56(4), 525-536 (2010).
12. Dominguez SR, Briese T, Palacios G, et al. Multiplex MassTag-PCR for respiratory pathogens in pediatric nasopharyngeal washes negative by conventional diagnostic testing shows a high prevalence of viruses belonging to a newly recognized rhinovirus clade. J. Clin. Virol. 43(2), 219-222 (2008).
13. Ecker DJ, Sampath R, Blyn LB, et al. Rapid identification and strain-typing of respiratory pathogens for epidemic surveillance. Proc. Natl Acad. Sci. USA 102(22), 8012-8017 (2005).
14. Jurinke C, Oeth P, van den Boom D. MALDI-TOF mass spectrometry: a versatile tool for high-performance DNA analysis. Mol. Biotechnol. 26(2), 147-164 (2004).
15. Hofstadler SA, Sannes-Lowery KA, Hannis JC. Analysis of nucleic acids by FTICR MS. Mass Spectrom. Rev. 24(2), 265-285 (2005).
16. Doktycz MJ, Hurst GB, Habibi-Goudarzi S, et al. Analysis of polymerase chain reaction-amplified DNA products by mass spectrometry using matrix-assisted laser desorption and electrospray: current status. Anal. Biochem. 230(2), 205-214 (1995).
17. Ecker DJ, Sampath R, Massire C, et al. Ibis T5000: a universal biosensor approach for microbiology. Nat. Rev. Microbiol. 6(7), 553-558 (2008).
18. Jurinke C, van den Boom D, Cantor CR, Köster H. The use of MassARRAY technology for high throughput genotyping. Adv. Biochem. Eng. Biotechnol. 77, 57-74 (2002).
19. Cullinan A, Cantor C. Sequenom, Inc. Pharmacogenomics 9(9), 1211-1215 (2008).
20. Jurinke C, Zöllner B, Feucht HH, et al. Detection of hepatitis B virus DNA in serum samples via nested PCR and MALDI-TOF mass spectrometry. Genet. Anal. 13(3), 67-71 (1996).
21. Higuchi R, Dollinger G, Walsh PS, Griffith R. Simultaneous amplification and detection of specific DNA sequences. Biotechnology (NY) 10(4), 413-417 (1992).
22. Monforte JA, Becker CH. High-throughput DNA analysis by time-of-flight mass spectrometry. Nat. Med. 3(3), 360-362 (1997).
23. Rees JC, Voorhees KJ. Simultaneous detection of two bacterial pathogens using bacteriophage amplification coupled with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 19(19), 2757-2761 (2005).
24. Sjöholm MI, Dillner J, Carlson J. Multiplex detection of human herpesviruses from archival specimens by using matrix-assisted laser desorption ionizationtime of flight mass spectrometry. J. Clin. Microbiol. 46(2), 540-545 (2008).
25. Yang H, Yang K, Khafagi A, et al. Sensitive detection of human papillomavirus in cervical, head/neck, and schistosomiasisassociated bladder malignancies. Proc. Natl Acad. Sci. USA 102(21), 7683-7688 (2005).
26. Luan J, Yuan J, Li X, et al. Multiplex detection of 60 hepatitis B virus variants by maldi-tof mass spectrometry. Clin. Chem. 55(8), 1503-1509 (2009).
27. Deyde VM, Sampath R, Gubareva LV. RT-PCR/electrospray ionization mass spectrometry approach in detection and characterization of influenza viruses. Expert Rev. Mol. Diagn. 11(1), 41-52 (2011).
28. Michael K, Harder TC, Mettenleiter TC, Karger A. Diagnosis and strain differentiation of avian influenza viruses by restriction fragment mass analysis. J. Virol. Methods 158(1-2), 63-69 (2009).
29. Ilina EN, Malakhova MV, Generozov EV, Nikolaev EN, Govorun VM. Matrix-assisted laser desorption ionization-time of flight (mass spectrometry) for hepatitis C virus genotyping. J. Clin. Microbiol. 43(6), 2810-2815 (2005).
30. Han KH, Hong SP, Choi SH, et al. Comparison of multiplex restriction fragment mass polymorphism and sequencing analyses for detecting entecavir resistance in chronic hepatitis B. Antivir. Ther. (Lond.) 16(1), 77-87 (2011).
31. Lefmann M, Honisch C, Böcker S, et al. Novel mass spectrometry-based tool for genotypic identification of mycobacteria. J. Clin. Microbiol. 42(1), 339-346 (2004).
32. Hofstadler SA, Sampath R, Blyn LB, et al. TIGER: the universal biosensor. Int. J. Mass Spectrom. 242(1), 23-41 (2005).
33. Cordey S, Thomas Y, Suter P, Kaiser L. Pilot evaluation of RT-PCR/electrospray ionization mass spectrometry (PLEX-ID/Flu assay) on influenza-positive specimens. Open Virol. J. 6, 64-67 (2012).
34. Ecker JA, Massire C, Hall TA, et al. Identification of Acinetobacter species and genotyping of Acinetobacter baumannii by multilocus PCR and mass spectrometry. J. Clin. Microbiol. 44(8), 2921-2932 (2006).
35. Sampath R, Hofstadler SA, Blyn LB, et al. Rapid identification of emerging pathogens: Coronavirus. Emerging Infect. Dis. 11(3), 373-379 (2005).
36. Eshoo MW, Whitehouse CA, Zoll ST, et al. Direct broad-range detection of ? viruses in mosquito extracts. Virology 368(2), 286-295 (2007).
37. Sampath R, Russell KL, Massire C, et al. Global surveillance of emerging Influenza virus genotypes by mass spectrometry. PLoS ONE 2(5), e489 (2007).
38. Grant RJ, Baldwin CD, Nalca A, et al. Application of the Ibis-T5000 pan-orthopoxvirus assay to quantitatively detect monkeypox viral loads in clinical specimens from macaques experimentally infected with aerosolized monkeypox virus. Am. J. Trop. Med. Hyg. 82(2), 318-323 (2010).
39. Grant-Klein RJ, Baldwin CD, Turell MJ, et al. Rapid identification of vector-borne flaviviruses by mass spectrometry. Mol. Cell. Probes 24(4), 219-228 (2010).
40. Metzgar D, Baynes D, Myers CA, et al. Initial identification and characterization of an emerging zoonotic influenza virus prior to pandemic spread. J. Clin. Microbiol. 48(11), 4228-4234 (2010).
41. Hofstadler SA, Sannes-Lowery KA, Crooke ST, et al. Multiplexed screening of neutral mass-tagged RNA targets against ligand libraries with electrospray ionization FTICR MS: a paradigm for high-throughput affinity screening. Anal. Chem. 71(16), 3436-3440 (1999).
42. Thompson A, Prescott M, Chelebi N, Smith J, Brown T, Schmidt G. Electrospray ionisation-cleavable tandem nucleic acid mass tag-peptide nucleic acid conjugates: synthesis and applications to quantitative genomic analysis using electrospray ionisation-MS/MS. Nucleic Acids Res. 35(4), e28 (2007).
43. Stauber J, El Ayed M, Wisztorski M, Day R, Fournier I, Salzet M. Polymerase chain reaction and immunoassay-matrix assisted laser desorption mass spectrometry using tag-mass technology: new tools to break down quantification limits and multiplexes. Anal. Chem. 81(22), 9512-9521 (2009).
44. Shaler TA, Tan Y, Wickham JN, Wu KJ, Becker CH. Analysis of enzymatic DNA sequencing reactions by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 9(10), 942-947 (1995).
45. Köster H, Tang K, Fu DJ, et al. A strategy for rapid and efficient DNA sequencing by mass spectrometry. Nat. Biotechnol. 14(9), 1123-1128 (1996).
46. Stanssens P, Zabeau M, Meersseman G, et al. High-throughput MALDI-TOF discovery of genomic sequence polymorphisms. Genome Res. 14(1), 126-133 (2004).
47. Shendure JA, Porreca GJ, Church GM. Overview of DNA sequencing strategies. Curr. Protoc. Mol. Biol. Chapter 7, Unit 7.1 (2008).
48. Ragoussis J, Elvidge GP, Kaur K, Colella S. Matrix-assisted laser desorption/ionisation, time-of-flight mass spectrometry in genomics research. PLoS Genet. 2(7), e100 (2006).
49. Deng YB, Nagae G, Midorikawa Y, et al. Identification of genes preferentially methylated in hepatitis C virus-related hepatocellular carcinoma. Cancer Sci. 101(6), 1501-1510 (2010).
50. Ehrich M, Nelson MR, Stanssens P, et al. Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. Proc. Natl Acad. Sci. USA 102(44), 15785-15790 (2005).
51. Hoelzer K, Shackelton LA, Parrish CR. Presence and role of cytosine methylation in DNA viruses of animals. Nucleic Acids Res. 36(9), 2825-2837 (2008).
52. Vivekanandan P, Daniel HD, Kannangai R, Martinez-Murillo F, Torbenson M. Hepatitis B virus replication induces methylation of both host and viral DNA. J. Virol. 84(9), 4321-4329 (2010).
53. Tost J, Schatz P, Schuster M, Berlin K, Gut IG. Analysis and accurate quantification of CpG methylation by MALDI mass spectrometry. Nucleic Acids Res. 31(9), e50 (2003).
54. Lok AS, Seeff LB, Morgan TR, et al.; HALT-C Trial Group. Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. Gastroenterology 136(1), 138-148 (2009).
55. von Wintzingerode F, Böcker S, Schlötelburg C, et al. Base-specific fragmentation of amplified 16S rRNA genes analyzed by mass spectrometry: a tool for rapid bacterial identification. Proc. Natl Acad. Sci. USA 99(10), 7039-7044 (2002).
56. Honisch C, Mosko M, Arnold C, Gharbia SE, Diel R, Niemann S. Replacing reverse line blot hybridization spoligotyping of the Mycobacterium tuberculosis complex. J. Clin. Microbiol. 48(5), 1520-1526 (2010).
57. Honisch C, Chen Y, Mortimer C, et al. Automated comparative sequence analysis by base-specific cleavage and mass spectrometry for nucleic acid-based microbial typing. Proc. Natl Acad. Sci. USA 104(25), 10649-10654 (2007).
58. Il'ina EN, Malakhova MV, Generozov EV, Govorun VM, Archakov AI, Pokrovskii VI. Using the mass spectrometry analysis for hepatitis C virus typing. Biomed. Khim. 51(1), 41-47 (2005).
59. Kim YJ, Kim SO, Chung HJ, et al. Population genotyping of hepatitis C virus by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry analysis of short DNA fragments. Clin. Chem. 51(7), 1123-1131 (2005).
60. Hong SP, Shin SK, Lee EH, et al. Highresolution human papillomavirus genotyping by MALDI-TOF mass spectrometry. Nat. Protoc. 3(9), 1476-1484 (2008).
61. Jurinke C, van den Boom D, Cantor CR, Köster H. Automated genotyping using the DNA MassArray technology. Methods Mol. Biol. 187, 179-192 (2002).
62. Söderlund-Strand A, Dillner J, Carlson J. High-throughput genotyping of oncogenic human papilloma viruses with MALDITOF mass spectrometry. Clin. Chem. 54(1), 86-92 (2008).
63. Malakhova MV, Ilina EN, Govorun VM, et al. Hepatitis B virus genetic typing using mass-spectrometry. Bull. Exp. Biol. Med. 147(2), 220-225 (2009).
64. Ganova-Raeva L, Ramachandran S, Honisch C, Forbi JC, Zhai X, Khudyakov Y. Robust hepatitis B virus genotyping by mass spectrometry. J. Clin. Microbiol. 48(11), 4161-4168 (2010).
65. Ganova-Raeva LM, Dimitrova ZE, Campo DS, Khudyakov Y. Application of mass spectrometry to molecular surveillance of hepatitis B and C viral infections. Antivir. Ther. 17(7 Pt B), 1477-1482 (2012).
66. Jurinke C, Denissenko MF, Oeth P, Ehrich M, van den Boom D, Cantor CR. A single nucleotide polymorphism based approach for the identification and characterization of gene expression modulation using MassARRAY. Mutat. Res. 573(1-2), 83-95 (2005).
67. Tang K, Oeth P, Kammerer S, et al. Mining disease susceptibility genes through SNP analyses and expression profiling using MALDI-TOF mass spectrometry. J. Proteome Res. 3(2), 218-227 (2004).
68. Pusch W, Wurmbach JH, Thiele H, Kostrzewa M. MALDI-TOF mass spectrometry-based SNP genotyping. Pharmacogenomics 3(4), 537-548 (2002).
69. Woo HY, Park H, Kim BI, Jeon WK, Cho YK, Kim YJ. Comparison of mass spectrometric analysis and TRUGENE HBV genotyping for monitoring lamivudine resistance in chronic hepatitis B patients. Antivir. Ther. (Lond.) 12(1), 7-13 (2007).
70. Emonet S, Shah HN, Cherkaoui A, Schrenzel J. Application and use of various mass spectrometry methods in clinical microbiology. Clin. Microbiol. Infect. 16(11), 1604-1613 (2010).
71. Pawlotsky JM. Genetic heterogeneity and properties of hepatitis C virus. Acta Gastroenterol. Belg. 61(2), 189-191 (1998).
72. Villet S, Billioud G, Pichoud C, et al. In vitro characterization of viral fitness of therapy-resistant hepatitis B variants. Gastroenterology 136(1), 168-176.e2 (2009).
73. Lee CH, Kim SO, Byun KS, et al. Predominance of hepatitis B virus YMDD mutants is prognostic of viral DNA breakthrough. Gastroenterology 130(4), 1144-1152 (2006).
74. Hong SP, Kim NK, Hwang SG, et al. Detection of hepatitis B virus YMDD variants using mass spectrometric analysis of oligonucleotide fragments. J. Hepatol. 40(5), 837-844 (2004).
75. Kim HS, Han KH, Ahn SH, et al. Evaluation of methods for monitoring drug resistance in chronic hepatitis B patients during lamivudine therapy based on mass spectrometry and reverse hybridization. Antivir. Ther. (Lond.) 10(3), 441-449 (2005).
76. Ayers M, Siu K, Roberts E, Garvin AM, Tellier R. Characterization of hepatitis C virus quasispecies by matrix-assisted laser desorption ionization-time of flight (mass spectrometry) mutation detection. J. Clin. Microbiol. 40(9), 3455-3462 (2002).
77. Yea C, Bukh J, Ayers M, Roberts E, Krajden M, Tellier R. Monitoring of hepatitis C virus quasispecies in chronic infection by matrix-assisted laser desorption ionization-time of flight mass spectrometry mutation detection. J. Clin. Microbiol. 45(3), 1053-1057 (2007).
78. Amexis G, Oeth P, Abel K, et al. Quantitative mutant analysis of viral quasispecies by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Proc. Natl Acad. Sci. USA 98(21), 12097-12102 (2001).
79. Widell A, Christensson B, Wiebe T, et al. Epidemiologic and molecular investigation of outbreaks of hepatitis C virus infection on a pediatric oncology service. Ann. Intern. Med. 130(2), 130-134 (1999).
80. Nainan OV, Lu L, Gao FX, Meeks E, Robertson BH, Margolis HS. Selective transmission of hepatitis C virus genotypes and quasispecies in humans and experimentally infected chimpanzees. J. Gen. Virol. 87(Pt 1), 83-91 (2006).
81. Ganova-Raeva LM, Dimitrova ZE, Campo DS, et al. Detection of hepatitis C virus transmission by use of DNA mass spectrometry. J. Infect. Dis. 207(6), 999-1006 (2012).
82. Dimitrova Z, Campo DS, Ramachandran S, et al. Evaluation of viral heterogeneity using next-generation sequencing, end-point limiting-dilution and mass spectrometry. In Silico Biol. 11(5), 183-192 (2012).
83. Khudyakov Y. Molecular surveillance of hepatitis C. Antivir. Ther. (Lond.) 17(7 Pt B), 1465-1470 (2012).
84. Lara J, Khudyakov Y. Epistatic connectivity among HCV genomic sites as a genetic marker of interferon resistance. Antivir. Ther. 12, 1471-1475 (2012).
85. Endimiani A, Hujer KM, Hujer AM, et al. Are we ready for novel detection methods to treat respiratory pathogens in hospitalacquired pneumonia? Clin. Infect. Dis. 52(Suppl. 4), S373-S383 (2011).
86. Bissonnette L, Bergeron MG. Multiparametric Technologies for the diagnosis of syndromatic infections. Clin. Microbiol. Newslett. 34(20), 159-168 (2012).